Fiocruz International News - September 2024

Study shows impact of the pandemic on health indicators in 185 countries
Research by Fiocruz Minas made a projection for the period 2021/2030. Countries with the lowest incomes could see a 16% drop in the 43 indicators assessed, a much more significant decline than the 3% estimated for high-income countries
Foundation is part now of Africa CDC Emergency Advisory Group
The president of Fiocruz, Mario Moreira, joined the Emergency Advisory Group set up by the African Center for Disease Control and Prevention (Africa CDC). The group acts as the main advisory body to the director, a position held by Jean Kaseya
Fiocruz joins global network of vaccine manufacturers
Brazil’s Bio-Manguinhos/Fiocruz is the newest member of CEPI’s network of vaccine manufacturers in the Global South, working to support faster and more equitable responses to future emerging infectious disease threats
Unprecedented research detects cocaine contamination in sharks
The Oswaldo Cruz Institute (IOC/Fiocruz) has detected the contamination of sharks by cocaine and its metabolite, benzoylecgonium, in Rio. The data draws attention to the high quantity of the drug that is consumed in the city
Fiocruz's new virus collection will help develop vaccines and treatments
Foundation has taken a significant step by recognizing the Virus Collection of the Biodiversity and Health Biobank (CVBBS), made up of viral strains
WHO and Foundation hold meeting to align emergency response actions
The meeting brought together leaders from Fiocruz and directors of the WHO Health Emergencies Program and took place after the Global Pandemic Preparedness Summit
Agreement will allow the technological development of radiopharmaceuticals
In partnership with the University of Coimbra, Fiocruz has signed an agreement for the technological development of radiopharmaceuticals and the registration of products in Brazil. Collaboration happens through Farmanguinhos